Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Glioma 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Basal Cell 1

Interventions

Specimen Handling 4Nivolumab 4Magnetic Resonance Spectroscopy 3HhAntag691 3Ipilimumab 2CTLA-4 Antigen 2Biopsy 2talimogene laherparepvec 1prednylidene 1deltacortene 1daromun 1Therapeutics 1Sirolimus 1Prednisone 1IFL protocol 1Folfox protocol 1Blood Specimen Collection 1Bevacizumab 1Antineoplastic Protocols 1Aminolevulinic Acid 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Basal Cell × 1-phenyl-3,3-dimethyltriazene × 30 days × Clear all
NCT05020912 2026-06-01

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Case Comprehensive Cancer Center

Phase 2 Active not recruiting
18 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡